Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan

Abstract The spreading of viral hepatitis among injecting drug users (IDU) is an emerging public health concern. This study explored the prevalence and the risks of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among IDU-dominant prisoners in Taiwan. HBV surface antige...

Full description

Bibliographic Details
Main Authors:	Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, Pei-Chien Tsai, Meng-Hsuan Hsieh, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Wen-Yu Chang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-04-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-87975-5

Similar Items

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
by: Ming-Lun Yeh, et al.
Published: (2017-01-01)

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma
by: Ming-Lun Yeh, et al.
Published: (2015-02-01)

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection
by: Chung-Feng Huang, et al.
Published: (2015-05-01)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients
by: Ching-I Huang, et al.
Published: (2017-08-01)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
by: Chuan-Pin Lin, et al.
Published: (2021-01-01)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
by: Tsai Jung-Fa, et al.
Published: (2005-04-01)

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
by: Ming-Yen Hsieh, et al.
Published: (2012-02-01)

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
by: Po-Cheng Liang, et al.
Published: (2018-01-01)

Association of hyperuricemia with disease severity in chronic hepatitis C patients.
by: Tyng-Yuan Jang, et al.
Published: (2018-01-01)

Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment
by: Tzu‐Sheng Cheng, et al.
Published: (2021-04-01)

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
by: Tyng-Yuan Jang, et al.
Published: (2021-01-01)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
by: Tyng-Yuan Jang, et al.
Published: (2021-04-01)

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan
by: Chung-Feng Huang, et al.
Published: (2021-01-01)

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
by: Pei-Chien Tsai, et al.
Published: (2017-01-01)

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
by: Ming-Lun Yeh, et al.
Published: (2016-11-01)

Qualitative Application of COBAS AMPLICOR HCV Test Version 2.0 Assays in Patients with Chronic Hepatitis C Virus Infection and Comparison of Clinical Performance with Version 1.0
by: Ming-Yen Hsieh, et al.
Published: (2007-07-01)

Interplay of COVID-19 and physiological dysfunctions
by: Yu-Hsiu Chang, et al.
Published: (2020-01-01)

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma
by: Zu‐Yau Lin, et al.
Published: (2021-07-01)

Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
by: Yi-Shan Tsai, et al.
Published: (2020-07-01)

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
by: Ming‐Lun Yeh, et al.
Published: (2019-10-01)

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2015-01-01)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
by: Po-Yao Hsu, et al.
Published: (2021-01-01)

Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.
by: Chung-Feng Huang, et al.
Published: (2013-01-01)

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
by: Tyng-Yuan Jang, et al.
Published: (2017-01-01)

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
by: Ta-Wei Liu, et al.
Published: (2018-01-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
by: Jia-Jung Lee, et al.
Published: (2020-01-01)

Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication
by: Chung‐Feng Huang, et al.
Published: (2020-11-01)

The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseases
by: Yi-Hung Lin, et al.
Published: (2016-07-01)

Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
by: Chung-Feng Huang, et al.
Published: (2017-03-01)

Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
by: Ming-Lung Yu, et al.
Published: (2018-06-01)

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan
by: Chia-Yen Dai, et al.
Published: (2013-08-01)

Alström Syndrome with Acute Pancreatitis: A Case Report
by: Wen-Chih Wu, et al.
Published: (2003-07-01)

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2019-01-01)

Coagulation‐related inflammatory pseudotumor of liver
by: Ching‐Reigh Hsieh, et al.
Published: (2021-06-01)

Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients
by: Jeng-Fu Yang, et al.
Published: (2009-08-01)

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
by: Ta-Ya Lin, et al.
Published: (2017-06-01)

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment
by: Chung-Feng Huang, et al.
Published: (2017-02-01)

Hepatocellular Carcinoma Associated With Liver Abscess
by: Ching-I Huang, et al.
Published: (2009-10-01)

Why is In-hospital Diagnosis of Pulmonary Tuberculosis Delayed in Southern Taiwan?
by: Chun-Yu Lin, et al.
Published: (2010-04-01)